Melaleuca bracteata

Melaleuca bracteata · Accepted scientific name

Scientific literature: Moderate (113 studies) · ★★★☆☆

Scientifically known as Melaleuca bracteata, is a resilient shrub native to Australia, celebrated for its medicinal potential. Belonging to the Myrtaceae family, this plant contains essential oils with potent antimicrobial and anti-inflammatory properties. It serves as a valuable botanical resource in traditional healing and modern pharmacological research.

Family
Not available
Native range
Australasia
Parts used
Not available
Common names
Not available
Scientific synonyms
Not available

Names and Synonyms

Scientific Names

Accepted name

Melaleuca bracteata

Distribution

This plant, known scientifically as Melaleuca bracteata, is native to the diverse landscapes of Australia. Its geographical range is quite extensive, stretching across several distinct regions of the continent. It can be found growing in the eastern states of New South Wales and Queensland. Additionally, the species inhabits much of the central and western portions of the country, including the Northern Territory and Western Australia. Finally, its distribution extends further south into the state of South Australia.

Region Area
Australia New South Wales
Australia Northern Territory
Australia Queensland
Australia South Australia
Australia Western Australia

Sources: The World Checklist of Vascular Plants (WCVP)

Botanical Identification

Life history

The life history of Melaleuca bracteata is characterized by its status as a perennial species, ensuring its long-term presence within its ecological niche. As a phanerophyte, the plant maintains its photosynthetic organs on elevated structures, specifically categorized within the life form profiles of both phanerophyte and nanophanerophyte classifications. This growth habit is complemented by its evergreen nature, meaning it retains its foliage throughout the year without undergoing a deciduous phase.

Deciduousness :
evergreen
Life form :
phanerophyte
Lifecycle :
perennial

Morphology

The morphology of Melaleuca bracteata is characterized by a woody growth habit that allows it to function as a self-supporting structure. Depending on environmental conditions and developmental stages, the plant exhibits a versatile growth form, manifesting as either a shrub or a tree. As a terrestrial species, it is neither aquatic nor an epiphyte, and it maintains an independent existence as a non-parasitic organism. The physical stature of the plant is quite variable, with heights ranging from a minimum of 1 m to a maximum of 15 m, resulting in a mean plant height of approximately 8 m.

Aquatic :
terrestrial
Climber :
self-supporting
Epiphyte :
terrestrial
Growth form :
tree
Growth form :
shrub
Parasite :
independent
Plant height max:
15 m
Plant height mean:
8 m
Plant height min:
1 m
Woodiness :
woody

Physiology

The physiology of Melaleuca bracteata is characterized by its specific photosynthetic and morphological adaptations. This species utilizes the C3 photosynthetic pathway, which dictates its carbon fixation processes and metabolic efficiency. Morphologically, the plant exhibits specialized leaf dimensions, with leaf lengths ranging from a minimum of 1 cm to a maximum of 2.8 cm. The leaf width is similarly constrained, measuring between a minimum of 0.15 cm and a maximum of 0.3 cm, reflecting a narrow, linear leaf structure. Additionally, regarding its nutrient cycling capabilities, the plant does not function as a nitrogen fixer.

Leaf length max:
2.8 cm
Leaf length min:
1 cm
Leaf width max:
0.3 cm
Leaf width min:
0.15 cm
Nitrogen fixer :
no
Photosynthetic pathway :
C3

Reproduction

The reproduction of Melaleuca bracteata is characterized by a biotic pollination syndrome, relying heavily on animal vectors to facilitate fertilization. Specifically, the plant utilizes insect-mediated pollination, with bees playing a significant role in the transfer of pollen. Following successful pollination, the plant produces seeds that exhibit a very fine and lightweight profile. The individual seed mass is highly consistent, ranging from a minimum of 3.7e-05 g to a maximum of 5.8e-05 g, with an average seed mass recorded at 4.5e-05 g.

Pollination syndrome :
insect
Pollination syndrome :
bee
Pollination syndrome :
biotic
Seed mass max:
5.8e-05 g
Seed mass mean:
4.5e-05 g
Seed mass min:
3.7e-05 g

Sources: Global Inventory of Floras and Traits (GIFT)

Chemicals

Melaleuca bracteata has 8 reported phytochemicals identified across 0 scientific publications and several other databases. The most consistently reported chemicals include ALPHA-PHELLANDRENE, CINNAMIC ACID, Cinnamyl cinnamate, EO, Methyl eugenol.

Chemicals reported in Melaleuca bracteata
Chemical Supporting sources Consensus
ALPHA-PHELLANDRENE 1 supporting sources ★☆☆☆☆
CINNAMIC ACID 1 supporting sources ★☆☆☆☆
Cinnamyl cinnamate 1 supporting sources ★☆☆☆☆
EO 1 supporting sources ★☆☆☆☆
Methyl eugenol 1 supporting sources ★☆☆☆☆
cinnamaldehyde 1 supporting sources ★☆☆☆☆
cinnamyl alcohol 1 supporting sources ★☆☆☆☆
eugenol 1 supporting sources ★☆☆☆☆

ALPHA-PHELLANDRENE

  1. Dr. Duke

CINNAMIC ACID

  1. Dr. Duke

Cinnamyl cinnamate

  1. Dr. Duke

EO

  1. Dr. Duke

Methyl eugenol

  1. Dr. Duke

cinnamaldehyde

  1. Dr. Duke

cinnamyl alcohol

  1. Dr. Duke

eugenol

  1. Dr. Duke

Activities

Melaleuca bracteata has 105 reported activities identified across 0 scientific publications and several other databases. The most consistently reported activities include Acaricide, Adrenergic, Aldose-Reductase-Inhibitor, Allelochemic, Allergenic.

Activities reported in Melaleuca bracteata
Activity Supporting sources Consensus
Acaricide 1 supporting sources ★☆☆☆☆
Adrenergic 1 supporting sources ★☆☆☆☆
Aldose-Reductase-Inhibitor 1 supporting sources ★☆☆☆☆
Allelochemic 1 supporting sources ★☆☆☆☆
Allergenic 1 supporting sources ★☆☆☆☆
Analgesic 1 supporting sources ★☆☆☆☆
Anesthetic 1 supporting sources ★☆☆☆☆
AntiTNF 1 supporting sources ★☆☆☆☆
Antiaggregant 1 supporting sources ★☆☆☆☆
Antiarachidonate 1 supporting sources ★☆☆☆☆

Acaricide

  1. Dr. Duke

Adrenergic

  1. Dr. Duke

Aldose-Reductase-Inhibitor

  1. Dr. Duke

Allelochemic

  1. Dr. Duke

Allergenic

  1. Dr. Duke

Analgesic

  1. Dr. Duke

Anesthetic

  1. Dr. Duke

AntiTNF

  1. Dr. Duke

Antiaggregant

  1. Dr. Duke

Antiarachidonate

  1. Dr. Duke